Drug resistant epilepsy participants will be defined as having clinically documented seizures with consistent EEG evidence as defined by the 1981 International Classification of Epileptic Seizures refractory to standard anti-seizure treatment for at least one year prior to enrolling in this study and with an average of at least one seizure per month This criterion will be established by preliminary screening in the NINDS Clinical Epilepsy Section outpatient clinic under protocol 01-N-0139 and if necessary inpatient video- EEG monitoring Seizure focus localization will be determined by standard clinical neurophysiologic and imaging studies Prior or concurrent enrollment in 01-N-0139 is required 